Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development: a Randomized Control Trial

NCT06847932 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.

NCT NCT06847932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06847932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development: a Randomized Control Trial
Lead sponsor
National Defense Medical Center, Taiwan
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
October 1, 2026
Enrollment
14,726 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), atrial arrhythmias, atrial fibrillation (af), electrocardiogram, premature atrial complexes